by Corporate Communications/July 9, 2024
![Boehringer Ingelheim logo_dark green](/sites/default/files/2023-12/Untitled%20design%20%2837%29.png)
DULUTH, GA | Boehringer Ingelheim, a leader in animal health innovation, has teamed up for the fifth year with WoofTrax, a fundraising app that supports animal shelters and rescues, to launch the Go for the Gold Challenge. This initiative allows participants to contribute to animal shelters by simply walking their dogs and using the WoofTrax app to record the walk.
This year, the collaboration includes both monetary donations and donated products to support shelters across the U.S. All donations are provided by the animal health business of Boehringer Ingelheim, the maker of some of the most widely used and well-respected vaccines, parasite control products and therapeutics for pets. The challenge runs through October 2024.
"At Boehringer Ingelheim, we care about the work animal shelters are doing to rehome pets and wanted to expand the relationship with WoofTrax to include product donations,” said Dr. Julie Ryan-Johnson, Associate Director of Shelters at Boehringer Ingelheim. “Through the Go for the Gold Challenge we can work together to protect shelter dogs in need. Take a step with us and make a difference by supporting the well-being of animals through this incredible initiative."
When individuals sign up for the Go for the Gold Challenge through the app, each walk will result in a dose of a parasite protection product being donated to a shelter dog in need. The challenge will donate up to 25,000 doses, valued at $825,000. Additionally, each walk will earn 5 cents for the participant's selected WoofTrax animal charity, with a maximum total challenge donation of $10,000.
WoofTrax, in collaboration with Boehringer Ingelheim, will allocate funds to the users’ selected animal shelter based on the number of walks taken during the challenge.
"We are thrilled to expand our relationship with Boehringer Ingelheim," said WoofTrax CEO Doug Hexter. "Our shared passion for supporting shelter animals and promoting healthy habits will make a significant impact on the lives of animals in shelters, improving their overall wellbeing."
To join the Go for the Gold Challenge, visit WoofTrax.com/SUFS.
About Boehringer Ingelheim
Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health. As one of the industry’s top investors in Research and Development, the company focuses on developing innovative therapies in areas of high unmet medical need. Independent since its foundation in 1885, Boehringer takes a long-term perspective, embedding sustainability along the entire value chain. More than 53,500 employees serve over 130 markets to build a healthier, more sustainable, and equitable tomorrow. Lean more at boehringer-ingelheim.com/us.
About Boehringer Ingelheim – Animal Health business
Boehringer Ingelheim provides first-in-class innovation for preventing and treating diseases in animals. The company offers a wide range of vaccines, parasite-control products, and medicines for pets, horses, and livestock to veterinarians, animal owners, farmers, and governments. As a leader in animal health, Boehringer Ingelheim values that the health of humans and animals is deeply connected and strives to make a difference for people, animals, and society. Learn more at www.boehringer-ingelheim.com/animal-health
WoofTrax
Founded in 2012 by pet enthusiast and dog lover, Doug Hexter, WoofTrax publishes a free mobile app that lets users support an animal charity of their choice just by walking their dog. WoofTrax is available on Google Play and the App Store. The app promotes healthy interaction between dogs and their owners. Each WoofTrax walk earns a donation for the pet owner’s chosen animal charity. Download the free app today, start walking with your best friend, and unleash the love for all dogs. For more information, please visit www.wooftrax.com.
Media Contact:
Brett Israel
Boehringer Ingelheim Animal Health
Director of PR and Communications, U.S. Pets
brett.israel@boehringer-ingelheim.com
©2024 Boehringer Ingelheim Animal Health USA Inc., Duluth, GA. All rights reserved. US-PET-0618-2024